Merck & Co., Inc. (JOBS) Outlook Misses View as Dollar Strengthens

December 4, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

NEW YORK (Reuters) - Merck & Co (NYSE:MRK - News), which has been hobbled by waning sales of several big medicines, gave a 2009 earnings and revenue outlook below Wall Street forecasts in large part because of the stronger dollar.

Twitter
LinkedIn
Facebook
Email
Print

Earnings

Merck & Co.